Literature DB >> 1310431

Does malignant small round cell tumor of the thoracopulmonary region (Askin tumor) constitute a clinicopathologic entity? An analysis of 30 cases with immunohistochemical and electron-microscopic support treated at the Institute Gustave Roussy.

G Contesso1, A Llombart-Bosch, P Terrier, A Peydro-Olaya, M Henry-Amar, O Oberlin, J L Habrand, J Dubousset, T Tursz, M Spielmann.   

Abstract

The morphology and clinical outcome of 30 patients with malignant small round cell tumors located in the thoracopulmonary region (Askin tumor) are reported. Histologically, all tumors had similar patterns, with small round-to-oval cells and a lobulated stroma. Immunohistochemical analysis always resulted in positive staining for one or several neural markers. No significant differences were found compared with the immunomarkers in 26 typical Ewing's sarcomas located outside the thoracic wall. In three specimens, electron microscopy confirmed the presence of membrane-bound neurosecretory granules. It was confirmed that there is a remarkable similarity among all malignant small round cell tumors, including Askin tumor and Ewing's sarcoma. Overall survival was poor with a 2-year rate of 38% and a 6-year rate of 14%.

Entities:  

Mesh:

Year:  1992        PMID: 1310431     DOI: 10.1002/1097-0142(19920215)69:4<1012::aid-cncr2820690431>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support.

Authors:  Antonio Llombart-Bosch; Isidro Machado; Samuel Navarro; Franco Bertoni; Patrizia Bacchini; Marco Alberghini; Apollon Karzeladze; Nikita Savelov; Semyon Petrov; Isabel Alvarado-Cabrero; Doina Mihaila; Philippe Terrier; Jose Antonio Lopez-Guerrero; Piero Picci
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

Review 2.  Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors.

Authors:  Maria Tsokos; Rita D Alaggio; Louis P Dehner; Paul S Dickman
Journal:  Pediatr Dev Pathol       Date:  2012

3.  Askin tumor with metastasis to the scalp: a histochemical, immunohistochemical and ultrastructural study.

Authors:  Naoto Kuroda; Tamotsu Takahashi; Toshiaki Moriki; Yusuke Okanoue; Hiroo Mizobuchi; Eriko Miyazaki; Yoshihiro Hayashi; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2006-12-21       Impact factor: 2.309

4.  Malignant peripheral neuroectodermal tumors in urology.

Authors:  H von Zitzewitz; C Düber; P Gutjahr; W Kersjes; M Thelen
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

5.  Treatment outcomes in 23 thoracic primitive neuroectodermal tumours: a retrospective study.

Authors:  Srikrishna Sirivella; Isaac Gielchinsky
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-02

6.  [Peripheral primitive neuroectodermal tumor with gastric primary location: about a new case].

Authors:  Amal Ankouz; Hicham Elbouhadouti; Jihane Lamrani; Abdesslam Bouassria; Abdelatif Louchi; Khalid Ait Taleb
Journal:  Pan Afr Med J       Date:  2010-08-20

Review 7.  Askin tumor: four case reports and a review of the literature.

Authors:  Qian Xu; Kai Xu; Chun Yang; Xiuli Zhang; Yankai Meng; Qiang Quan
Journal:  Cancer Imaging       Date:  2011-11-30       Impact factor: 3.909

8.  Askin tumor mimicking a hydatid cyst of the lung in children: case report.

Authors:  El Hassane Kabiri; Abderrahmane Al Bouzidi; Meryem Kabiri
Journal:  Pan Afr Med J       Date:  2014-02-25

Review 9.  Askin's tumor: a case report and literature review.

Authors:  Zineb Benbrahim; Samia Arifi; Khaoula Daoudi; Mounia Serraj; Bouchra Amara; Mohammed Chakib Benjelloun; Nawfel Mellas; Omar El Mesbahi
Journal:  World J Surg Oncol       Date:  2013-01-22       Impact factor: 2.754

10.  Treatment of an Askin tumor: A case report and review of the literature.

Authors:  Xue Dou; Hongjiang Yan; Renben Wang
Journal:  Oncol Lett       Date:  2013-07-24       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.